Putting the "Bio" Back Into Biomarkers: Orienting Proteomic Discovery Toward Biology and Away from the Measurement Platform (Editorial) Putting the "Bio" Back Into Biomarkers: Orienting Proteomic Discovery Toward Biology and Away from the Measurement Platform (Editorial)

Putting the "Bio" Back Into Biomarkers: Orienting Proteomic Discovery Toward Biology and Away from the Measurement Platform (Editorial‪)‬

Clinical Chemistry, 2008, Jan, 54, 1

    • $5.99
    • $5.99

Publisher Description

The discipline of mass spectrometry (MS)-based serum biomarker profiling is a relatively young field that was launched in a flourish of scientific hope and the clinical promise of a better cancer test (1-5). Nevertheless, the field has already undergone a rollercoaster cycle of optimism and disappointment and renewed enthusiasm during its brief 7-year history (1-8). Before 1999 very little effort was made to directly use MS (MALDI-TOF or ES) as a means to discover new blood biomarkers. Many scientists thought that serum was too complex for MS analysis, and dominated by contaminants, rendering these samples unacceptable for direct introduction into expensive and sophisticated MS research instruments. All of these arguments seemed to be overturned in 1998 when a new class of MALDI-TOF, surface-enhanced laser desorption and ionization (SELDI) was commercialized. Scientists with no formal training in MS saw SELDI as an opportunity to explore the application of MALDI MS to biomarker discovery. Although this method had relatively low resolution, it appeared to provide a fresh, one-step approach to the search for ion signatures of hundreds of candidate biomarkers. Importantly, SELDI-TOF offered a means to support a critical new hypothesis that was emerging in the protein biomarker field. This hypothesis abandoned the assumption that a single specific tumor cell-derived cancer biomarker existed. Instead, cascades of biomarkers were generated from the tumor tissue microenvironment through interactions between the tumor cells and the host cells (e.g., endothelial cells, stroma cells, and immune cells) (1, 5). The tissue-microenvironment hypothesis predicted that a panel of biomarkers could achieve a sensitivity and specificity superior to previous failed cancer biomarker searches (1, 5-8). In 2002 SELDI provided a means for discovering the ion signatures of these putative biomarkers, although their identity was unknown (1, 2).

GENRE
Science & Nature
RELEASED
2008
January 1
LANGUAGE
EN
English
LENGTH
8
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
188.6
KB
Biomarker Discovery and Validation (Editorials) Biomarker Discovery and Validation (Editorials)
2006
SELDI-TOF MS Whole Serum Proteomic Profiling with IMAC Surface Does Not Reliably Detect Prostate Cancer (Proteomics and Protein Markers) (Clinical Report) SELDI-TOF MS Whole Serum Proteomic Profiling with IMAC Surface Does Not Reliably Detect Prostate Cancer (Proteomics and Protein Markers) (Clinical Report)
2008
Principles of Translational Science in Medicine Principles of Translational Science in Medicine
2021
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report) Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry
2021
Bioinformatics and Biomarker Discovery Bioinformatics and Biomarker Discovery
2011
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report) Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey) Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
2007
Alanine Aminotransferase As an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease (Letters) (Letter to the Editor) Alanine Aminotransferase As an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease (Letters) (Letter to the Editor)
2007
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology) T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
2007
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers) Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998